dihexa human studies clinical trials DHX / PNB-0408 dihexa human studies clinical trials
Description
3 mL per vial Alcohol Swabs Two per day (vial + injection site) Goal: Support tissue recovery processes and cellular repair pathways based on experimental research
This merger affects how pharmacy benefits and medical coverage work together for Aetna members
Response was durable for a median of 9.5 months in the lower dosing group
Phase 2 & 3 trial data: up to 28.7% weight loss at 12 mg
